R
Ramakrishnan
About Ramakrishnan
Data last updated:
Ramakrishnan is a Director at Firstmed Therapeutics Private Limited (since 2024), Additional Director at Zeta Formulation Private Limited (since 2015) and Director at Curio Pharmaceuticals Private Limited (since 2020). The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹8.90 Cr; the largest is Firstmed Therapeutics Private Limited at ₹5.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Firstmed Therapeutics Private Limited U24232TN2012PTC136229 | Director | 18 May 2024 | 2012 | ₹5.38 Cr (FY 2025) | Active |
| Zeta Formulation Private Limited U24230TN2009PTC070757 | Additional Director | 07 Oct 2015 | 2009 | ₹3.52 Cr (FY 2025) | Active |
| Curio Pharmaceuticals Private Limited U24290PY2020PTC008635 | Director | 20 Nov 2020 | 2020 | Active |
Board colleagues of Ramakrishnan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manimegalai | 08966833 | Firstmed Therapeutics Private Limited , Curio Pharmaceuticals Private Limited | Director |
| Dhanasekaran Siva | 09312387 | Zeta Formulation Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramakrishnan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramakrishnan
Ramakrishnan currently holds 3 directorships: Firstmed Therapeutics Private Limited (Director, since 18 May 2024, revenue ₹5.38 Cr (FY 2025)); Zeta Formulation Private Limited (Additional Director, since 07 Oct 2015, revenue ₹3.52 Cr (FY 2025)); Curio Pharmaceuticals Private Limited (Director, since 20 Nov 2020).
Ramakrishnan was first appointed on 07 Oct 2015 as Additional Director at Zeta Formulation Private Limited. The most recent appointment on record is 18 May 2024 at Firstmed Therapeutics Private Limited.
The 2 current companies of Ramakrishnan that report revenue have a combined latest revenue of ₹8.90 Cr: Firstmed Therapeutics Private Limited ₹5.38 Cr (FY 2025); Zeta Formulation Private Limited ₹3.52 Cr (FY 2025).
The current boards of Ramakrishnan's companies include Manimegalai (Firstmed Therapeutics Private Limited), Dhanasekaran Siva (Zeta Formulation Private Limited).